BRAF V600E mutation
1 paper
- Humans1
Latest
3 in 12 monthsThe Lancet Haematology
Phenotype, treatment, and determinants of prognosis in Erdheim-Chester disease: an international, retrospective, cohort study
Cohort study of 1,174 peoplePopulations
bioRxiv
Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibition
Preprint: experiments in miceInterventions
Current Oncology Reports
Pharmacological Treatment for Adamantinomatous Craniopharyngioma
ReviewInterventions
Best Practice & Research Clinical Endocrinology & Metabolism
Decoding craniopharyngioma: From mechanisms to therapy
ReviewMechanisms
Biomedical and Environmental Sciences
Decoding the Molecular Mechanisms of BRAF V600E-Induced Nevi Formation
ReviewMechanisms
PNAS Nexus
Distinct senescence mechanisms restrain progression of dysplastic nevi
Cohort study in peopleCellular senescence
bioRxiv
Distinct senescence mechanisms restrain progression of dysplastic nevi
Preprint: cohort study in peopleCellular senescence